Measles Exposure at School: What to Do Within 72 Hours
If school officials report a possible measles exposure and your child may not have proof of immunity, act fast. CDC guidance includes MMR within 72 hours (for eligible people) and immune globulin within 6 days (for certain vulnerable groups). Measles symptoms usually start 7–14 days later—so know the warning signs.
Measles spreads extremely easily in indoor settings like classrooms. If your child’s school or daycare says someone may have measles, the safest next step is speed: call your child’s healthcare provider (or school health contact) right away to discuss whether your child needs post-exposure prophylaxis (PEP).
Here’s what families should do within the first 72 hours, and what to watch for during the 7–14 days after an exposure.
Why acting quickly matters
CDC tracks measles activity in the United States and continues to report outbreaks. When a school exposure happens, public health teams and clinicians may need to make time-sensitive decisions to reduce the risk of infection and complications—especially for babies, young children, pregnant people, and others at higher risk.
Key move: If you think you or your child were exposed, CDC advises calling a healthcare provider immediately—don’t wait for a rash.
What to do within 72 hours (and up to 6 days)
CDC guidance for measles PEP is for people who cannot readily show adequate evidence of measles immunity. There are two main options:
- MMR vaccine (for eligible people) if given within 72 hours of the initial exposure.
- Immune globulin (IG) if given within 6 days of the initial exposure for certain vulnerable people.
Important: CDC says do not administer MMR vaccine and IG simultaneously because this practice invalidates the vaccine.
Who is often prioritized for immune globulin (IG)?
CDC describes IG as generally reserved for close contacts who cannot get the MMR vaccine. People who can’t get MMR include:
- Infants younger than 6 months
- Pregnant women (CDC notes breastfeeding women can get MMR)
- People who are severely immunocompromised or who have other medical contraindications to vaccination
CDC also notes that IG PEP should be provided in coordination with local or state health departments.
What symptoms to watch for 7–14 days later
Measles symptoms typically begin 7 to 14 days after exposure. CDC describes a common pattern:
- First symptoms (often 7–14 days after infection): high fever, cough, runny nose, and red, watery eyes.
- 2–3 days after symptoms start: tiny white spots inside the mouth (Koplik spots) may appear.
- 3–5 days after symptoms begin: a measles rash often starts on the face near the hairline and spreads downward to the neck, trunk, arms, legs, and feet.
When to act: If symptoms develop, contact a healthcare provider promptly.
What caregivers and schools can do next
- Confirm the exposure timeline: write down the date of the possible exposure and which classrooms/activities were involved.
- Check immunization records: look for documented MMR doses or other evidence of immunity.
- Contact the right place immediately: your child’s clinician (and follow school instructions) so decisions can be made within the CDC PEP windows.
- Plan symptom monitoring: watch for signs for the 7–14 days after exposure, especially in higher-risk households.
What is known—and what remains uncertain
PEP is based on timing: CDC provides specific windows for MMR vaccine and IG after exposure. Whether PEP is recommended depends on the person’s situation (for example, whether they have adequate evidence of immunity and whether MMR is appropriate).
In other words: you don’t need to guess when to act. If you were told about a possible exposure, start with a same-day call so clinicians and public health teams can guide the safest next step within the recommended timeframes.
Key sources
- CDC Measles: Vaccine Considerations (Post-Exposure Prophylaxis)
- American Academy of Pediatrics (AAP) Measles Family Guidance
- PubMed: Measles Post-Exposure Prophylaxis Evidence (Journal Article)
Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.
This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.
